Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoyao Jieyu for Post-stroke Depression
ChiCTR-IPR-17010478Phase 4Recruiting
- Sponsor
- Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4 trial of Xiaoyao Jieyu in major depressive disorder (MDD) (3 arms), sponsored by Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: HAMD depression score. Started Jan 2017; status: recruiting.
02
Drugs
Xiaoyao Jieyu
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR-IPR-17010478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010478.